Published in Antimicrob Agents Chemother on May 01, 1997
Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin Microbiol Rev (1998) 5.36
Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis. Antimicrob Agents Chemother (1998) 2.00
Antibiotic resistance patterns of group B streptococcal clinical isolates. Infect Dis Obstet Gynecol (2004) 1.08
Antimicrobial non-susceptibility of cervico-vaginal and rectal Escherichia coli isolates is associated with phylogeny and plasmid carriage. Eur J Clin Microbiol Infect Dis (2009) 0.77
Epidemiology of group B streptococcal disease. Risk factors, prevention strategies, and vaccine development. Epidemiol Rev (1994) 2.46
Strategies for the prevention of early-onset neonatal group B streptococcal sepsis: a decision analysis. Obstet Gynecol (1994) 1.90
Antibiotic resistance patterns of group B streptococci in pregnant women. J Clin Microbiol (1990) 1.58
Adverse perinatal outcome and resistant Enterobacteriaceae after antibiotic usage for premature rupture of the membranes and group B streptococcus carriage. Obstet Gynecol (1993) 1.45
Microbiologic causes and neonatal outcomes associated with chorioamnion infection. Am J Obstet Gynecol (1991) 1.44
Is penicillin G a better choice than ampicillin for prophylaxis of neonatal group B streptococcal infections? Obstet Gynecol (1994) 1.30
Selective intrapartum prophylaxis for group B streptococcus colonization: management and outcome of newborns. Pediatrics (1994) 1.29
Antibiotic resistance and penicillin tolerance in clinical isolates of group B streptococci. Antimicrob Agents Chemother (1994) 1.27
Emergence of cross-resistance to beta-lactam antibiotics in fecal Escherichia coli and Klebsiella strains from neonates treated with ampicillin or cefuroxime. Antimicrob Agents Chemother (1990) 0.85
Susceptibility of 126 isolates of Escherichia coli from the cerebrospinal fluid of neonates to five antibiotics. J Antimicrob Chemother (1985) 0.82
Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol (1991) 20.49
HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet (1997) 7.52
Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis (1999) 6.85
Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis (1997) 6.64
Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med (2000) 5.15
Improved detection times for Mycobacterium avium complex and Mycobacterium tuberculosis with the BACTEC radiometric system. J Clin Microbiol (1985) 4.58
Relationships of vaginal Lactobacillus species, cervical Chlamydia trachomatis, and bacterial vaginosis to preterm birth. Obstet Gynecol (1988) 4.23
The identification of vaginal Lactobacillus species and the demographic and microbiologic characteristics of women colonized by these species. J Infect Dis (1999) 3.95
A review of premature birth and subclinical infection. Am J Obstet Gynecol (1992) 3.76
Bacterial vaginosis as a risk factor for post-cesarean endometritis. Obstet Gynecol (1990) 3.28
Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections. J Infect Dis (1996) 3.23
Control of the microbial flora of the vagina by H2O2-generating lactobacilli. J Infect Dis (1991) 3.17
Comparison of methods for diagnosing bacterial vaginosis among pregnant women. J Clin Microbiol (1989) 3.06
Sexually transmitted diseases in victims of rape. N Engl J Med (1990) 2.74
The association of occult amniotic fluid infection with gestational age and neonatal outcome among women in preterm labor. Obstet Gynecol (1992) 2.32
Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. N Engl J Med (2001) 2.23
Validity of the vaginal gram stain for the diagnosis of bacterial vaginosis. Obstet Gynecol (1996) 2.07
Tetracycline resistance and tetM in pathogenic urogenital bacteria. Antimicrob Agents Chemother (1986) 2.01
Factors associated with acquisition of, or persistent colonization by, vaginal lactobacilli: role of hydrogen peroxide production. J Infect Dis (2001) 1.96
Evaluation of affirm VP Microbial Identification Test for Gardnerella vaginalis and Trichomonas vaginalis. J Clin Microbiol (1994) 1.89
An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV). Cancer Epidemiol Biomarkers Prev (2001) 1.77
Vaginal Bacteroides species are associated with an increased rate of preterm delivery among women in preterm labor. J Infect Dis (1991) 1.77
Nitrocellulose filter blots for species identification of Mobiluncus curtisii and Mobiluncus mulieris. J Clin Microbiol (1984) 1.75
Pathophysiology and histopathology of group B streptococcal sepsis in Macaca nemestrina primates induced after intraamniotic inoculation: evidence for bacterial cellular invasion. J Infect Dis (1991) 1.68
Comparison of gram stain, DNA probe, and culture for the identification of species of Mobiluncus in female genital specimens. J Infect Dis (1985) 1.66
Association of cervical ectopy with heterosexual transmission of human immunodeficiency virus: results of a study of couples in Nairobi, Kenya. J Infect Dis (1991) 1.62
Sialidases (neuraminidases) in bacterial vaginosis and bacterial vaginosis-associated microflora. J Clin Microbiol (1992) 1.61
Sialidase (neuraminidase) activity among gram-negative anaerobic and capnophilic bacteria. J Clin Microbiol (1990) 1.58
Preclinical safety assessments of UC781 anti-human immunodeficiency virus topical microbicide formulations. Antimicrob Agents Chemother (2007) 1.58
Bacterial vaginosis and prematurity in Indonesia: association in early and late pregnancy. Am J Obstet Gynecol (1993) 1.53
Vaginal indicators of amniotic fluid infection in preterm labor. Obstet Gynecol (2001) 1.50
Genetic basis of tetracycline resistance in urogenital bacteria. Antimicrob Agents Chemother (1990) 1.48
Broad-spectrum bacterial rDNA polymerase chain reaction assay for detecting amniotic fluid infection among women in premature labor. Clin Infect Dis (1997) 1.48
Preclinical safety and efficacy assessments of dendrimer-based (SPL7013) microbicide gel formulations in a nonhuman primate model. Antimicrob Agents Chemother (2006) 1.47
The vaginal microflora of pig-tailed macaques and the effects of chlorhexidine and benzalkonium on this ecosystem. Sex Transm Dis (1997) 1.46
Microbiologic characteristics of Lactobacillus products used for colonization of the vagina. Obstet Gynecol (1990) 1.46
Optimization of media for detection of hydrogen peroxide production by Lactobacillus species. J Clin Microbiol (2003) 1.45
HIV infection and vaginal douching in central Africa. AIDS (1997) 1.42
Detection of Tet M and Tet O tetracycline resistance genes by polymerase chain reaction. Mol Cell Probes (1993) 1.41
Association of viridans group streptococci from pregnant women with bacterial vaginosis and upper genital tract infection. J Clin Microbiol (1988) 1.39
Bacterial vaginosis: review of treatment options and potential clinical indications for therapy. Clin Infect Dis (1999) 1.38
Group B streptococcal colonization and serotype-specific immunity in pregnant women at delivery. Obstet Gynecol (2000) 1.36
Effects of multiple applications of benzalkonium chloride and nonoxynol 9 on the vaginal epithelium in the pigtailed macaque (Macaca nemestrina). Am J Obstet Gynecol (1999) 1.34
Epidemiology and outcomes associated with moderate to heavy Candida colonization during pregnancy. Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol (1998) 1.32
Safety and efficacy evaluations for vaginal and rectal use of BufferGel in the macaque model. Sex Transm Dis (2004) 1.26
Levels of vaginal secretory leukocyte protease inhibitor are decreased in women with lower reproductive tract infections. Am J Obstet Gynecol (2000) 1.25
Hemagglutination, adherence, and surface properties of vaginal Lactobacillus species. J Infect Dis (1995) 1.24
Vaginal colonization by Escherichia coli as a risk factor for very low birth weight delivery and other perinatal complications. J Infect Dis (1997) 1.23
Effects of nonoxynol-9 on vaginal microflora and chlamydial infection in a monkey model. Sex Transm Dis (1997) 1.23
The genital flora of women with intraamniotic infection. Vaginal Infection and Prematurity Study Group. J Infect Dis (1995) 1.22
Rapid presumptive identification of black-pigmented gram-negative anaerobic bacteria by using 4-methylumbelliferone derivatives. J Clin Microbiol (1991) 1.18
Rapid diagnostic test that uses isocitrate lyase activity for identification of Yersinia pestis. J Clin Microbiol (1981) 1.18
Race/ethnicity, vaginal flora patterns, and pH during pregnancy. Sex Transm Dis (1999) 1.12
Effects of contraceptive method on the vaginal microbial flora: a prospective evaluation. J Infect Dis (2000) 1.10
Genital flora in pregnancy and its association with intrauterine growth retardation. J Clin Microbiol (1994) 1.09
The pig-tailed macaque rectal model: microflora and chlamydial infection. Sex Transm Dis (2001) 1.08
Microbiologic response to treatment of bacterial vaginosis with topical clindamycin or metronidazole. J Clin Microbiol (2005) 1.08
Reproducibility of a scoring system for gram stain diagnosis of bacterial vaginosis. J Clin Microbiol (1991) 1.06
Longitudinal study of the biotypes of Gardnerella vaginalis. J Clin Microbiol (1990) 1.04
The bacterial etiology of conjunctivitis in early infancy. Eye Prophylaxis Study Group. Am J Epidemiol (1993) 1.04
Intravaginal clindamycin treatment for bacterial vaginosis: effects on preterm delivery and low birth weight. Am J Obstet Gynecol (1995) 1.03
Amniotic fluid infection, cytokines, and adverse outcome among infants at 34 weeks' gestation or less. Obstet Gynecol (2001) 1.03
Comparative susceptibility of the Bacteroides fragilis group species and other anaerobic bacteria to meropenem, imipenem, piperacillin, cefoxitin, ampicillin/sulbactam, clindamycin and metronidazole. J Antimicrob Chemother (1993) 1.02
Evaluation of the enhanced rapid identification method for Gardnerella vaginalis. J Clin Microbiol (1989) 1.02
Analysis of restriction fragment length polymorphisms of the insertion sequence IS1381 in group B Streptococci. J Infect Dis (2000) 1.01
Effect of transport time, temperature, and concentration on the survival of group B streptococci in amies transport medium. J Clin Microbiol (2004) 1.00
Hormonal contraceptive use modulates the local inflammatory response to bacterial vaginosis. Sex Transm Infect (2007) 0.99
Diversity of surface protein expression in group B streptococcal colonizing & invasive isolates. Indian J Med Res (2004) 0.99
Amoxicillin treatment of bacterial vaginosis during pregnancy. Obstet Gynecol (1991) 0.99
Maternal peripartum complications associated with vaginal group B streptococci colonization. J Infect Dis (1999) 0.98
Mucopurulent cervicitis as a predictor of chlamydial infection and adverse pregnancy outcome. The Investigators of the Johns Hopkins Study of Cervicitis and Adverse Pregnancy Outcome. Sex Transm Dis (1992) 0.98
Vaginal myeloperoxidase and flora in the pig-tailed macaque. J Med Primatol (2000) 0.97
Metronidazole for bacterial vaginosis. A comparison of vaginal gel vs. oral therapy. J Reprod Med (2000) 0.97
Bacteria in the prostate tissue of men with idiopathic prostatic inflammation. J Urol (1997) 0.95
Douching and endometritis: results from the PID evaluation and clinical health (PEACH) study. Sex Transm Dis (2001) 0.95
A new proline aminopeptidase assay for diagnosis of bacterial vaginosis. Am J Obstet Gynecol (1991) 0.94
The effects of three nonoxynol-9 preparations on vaginal flora and epithelium. J Infect Dis (1999) 0.94
Amniotic fluid tumor necrosis factor-alpha and the risk of respiratory distress syndrome among preterm infants. Am J Obstet Gynecol (1997) 0.94
Comparison of the use of oligonucleotide probes, 4-methylumbelliferyl derivatives, and conventional methods for identifying Prevotella bivia. Clin Infect Dis (1995) 0.94
The effect of treatment regimens for vaginitis and cervicitis on vaginal colonization by lactobacilli. Sex Transm Dis (1996) 0.93
Bacteremia shortly after placental separation during cesarean delivery. Obstet Gynecol (1996) 0.92
Upper genital tract isolates at delivery as predictors of post-cesarean infections among women receiving antibiotic prophylaxis. Obstet Gynecol (1991) 0.90
Evaluation of a rapid enzyme immunoassay test for detection of group B Streptococcus. Obstet Gynecol (1991) 0.90
The sensitivity of three commonly used outcome measures to detect change amongst patients receiving inpatient rehabilitation following stroke. Clin Rehabil (2006) 0.90
Characterization of vaginal & rectal colonization with multiple serotypes of group B streptococci using multiple colony picks. Indian J Med Res (2004) 0.89
0.25% chlorhexidine gluconate gel. A protective topical microbicide. Sex Transm Dis (1998) 0.88
Use of nonoxynol-9 and changes in vaginal lactobacilli. J Infect Dis (1998) 0.86
Constitutive uptake and degradation of fatty acids by Yersinia pestis. J Bacteriol (1983) 0.86
Normal vaginal aerobic and anaerobic bacterial flora of the rhesus macaque (Macaca mulatta). J Med Primatol (1991) 0.86
Advances in diagnostic testing for vaginitis and cervicitis. J Reprod Med (1989) 0.85
High levels of Gardnerella vaginalis detected with an oligonucleotide probe combined with elevated pH as a diagnostic indicator of bacterial vaginosis. J Clin Microbiol (1992) 0.85
Evaluation of the Affirm Ambient Temperature Transport System for the detection and identification of Trichomonas vaginalis, Gardnerella vaginalis, and Candida species from vaginal fluid specimens. J Clin Microbiol (2001) 0.84
Production and characterization of monoclonal antibodies to Mobiluncus species. J Clin Microbiol (1988) 0.83
Lipopolysaccharide binding protein and soluble CD14 receptor protein in amniotic fluid and cord blood in patients at term. Am J Obstet Gynecol (1997) 0.83
Susceptibility of vaginal bacteria to metronidazole and tinidazole. Anaerobe (2006) 0.82
Characterization of unusual tetracycline-resistant gram-positive bacteria. Antimicrob Agents Chemother (1991) 0.82
Pregnancy complications associated with bacterial vaginosis and their estimated costs. Infect Dis Obstet Gynecol (1995) 0.81
Comparison of clindamycin phosphate vaginal cream with triple sulfonamide vaginal cream in the treatment of bacterial vaginosis. Sex Transm Dis (2001) 0.81
Characteristics of women in preterm labor associated with elevated C-reactive protein levels. Obstet Gynecol (1993) 0.80
Identification of two new antigenic subgroups within the genus Mobiluncus. J Clin Microbiol (1991) 0.78